305 related articles for article (PubMed ID: 21684715)
1. Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
Powell RJ; Comerota AJ; Berceli SA; Guzman R; Henry TD; Tzeng E; Velazquez O; Marston WA; Bartel RL; Longcore A; Stern T; Watling S
J Vasc Surg; 2011 Oct; 54(4):1032-41. PubMed ID: 21684715
[TBL] [Abstract][Full Text] [Related]
2. A randomized, controlled pilot study of autologous CD34+ cell therapy for critical limb ischemia.
Losordo DW; Kibbe MR; Mendelsohn F; Marston W; Driver VR; Sharafuddin M; Teodorescu V; Wiechmann BN; Thompson C; Kraiss L; Carman T; Dohad S; Huang P; Junge CE; Story K; Weistroffer T; Thorne TM; Millay M; Runyon JP; Schainfeld R;
Circ Cardiovasc Interv; 2012 Dec; 5(6):821-30. PubMed ID: 23192920
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow aspirate injection for treatment of critical limb ischemia with comparison to patients undergoing high-risk bypass grafts.
Giles KA; Rzucidlo EM; Goodney PP; Walsh DB; Powell RJ
J Vasc Surg; 2015 Jan; 61(1):134-7. PubMed ID: 25086735
[TBL] [Abstract][Full Text] [Related]
4. Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.
Iafrati MD; Hallett JW; Geils G; Pearl G; Lumsden A; Peden E; Bandyk D; Vijayaraghava KS; Radhakrishnan R; Ascher E; Hingorani A; Roddy S
J Vasc Surg; 2011 Dec; 54(6):1650-8. PubMed ID: 22019148
[TBL] [Abstract][Full Text] [Related]
5. Design and rationale of a randomized, double-blind, placebo-controlled phase III study for autologous bone marrow cell transplantation in critical limb ischemia: the BONe Marrow Outcomes Trial in Critical Limb Ischemia (BONMOT-CLI).
Amann B; Lüdemann C; Rückert R; Lawall H; Liesenfeld B; Schneider M; Schmidt-Lucke J
Vasa; 2008 Nov; 37(4):319-25. PubMed ID: 19003741
[TBL] [Abstract][Full Text] [Related]
6. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
7. Ethnic minorities with critical limb ischemia derive equal amputation risk reduction from autologous cell therapy compared with whites.
Wang SK; Green LA; Gutwein AR; Drucker NA; Babbey CM; Gupta AK; Fajardo A; Motaganahalli RL; Wilson MG; Murphy MP
J Vasc Surg; 2018 Aug; 68(2):560-566. PubMed ID: 29503004
[TBL] [Abstract][Full Text] [Related]
8. Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial.
Powell RJ; Marston WA; Berceli SA; Guzman R; Henry TD; Longcore AT; Stern TP; Watling S; Bartel RL
Mol Ther; 2012 Jun; 20(6):1280-6. PubMed ID: 22453769
[TBL] [Abstract][Full Text] [Related]
9. A multicenter comparison between autologous saphenous vein and heparin-bonded expanded polytetrafluoroethylene (ePTFE) graft in the treatment of critical limb ischemia in diabetics.
Dorigo W; Pulli R; Castelli P; Dorrucci V; Ferilli F; De Blasis G; Monaca V; Vecchiati E; Pratesi C;
J Vasc Surg; 2011 Nov; 54(5):1332-8. PubMed ID: 21840151
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia.
Lara-Hernandez R; Lozano-Vilardell P; Blanes P; Torreguitart-Mirada N; Galmés A; Besalduch J
Ann Vasc Surg; 2010 Feb; 24(2):287-94. PubMed ID: 20142004
[TBL] [Abstract][Full Text] [Related]
11. Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease.
Franz RW; Shah KJ; Pin RH; Hankins T; Hartman JF; Wright ML
J Vasc Surg; 2015 Sep; 62(3):673-80. PubMed ID: 26304481
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone marrow mononuclear cell therapy for critical limb ischemia is effective and durable.
Liang TW; Jester A; Motaganahalli RL; Wilson MG; G'Sell P; Akingba GA; Fajardo A; Murphy MP
J Vasc Surg; 2016 Jun; 63(6):1541-5. PubMed ID: 27021379
[TBL] [Abstract][Full Text] [Related]
13. Lower extremity arterial reconstruction for critical limb ischemia in diabetes.
Ballotta E; Toniato A; Piatto G; Mazzalai F; Da Giau G
J Vasc Surg; 2014 Mar; 59(3):708-19. PubMed ID: 24377943
[TBL] [Abstract][Full Text] [Related]
14. Defining utility and predicting outcome of cadaveric lower extremity bypass grafts in patients with critical limb ischemia.
Chang CK; Scali ST; Feezor RJ; Beck AW; Waterman AL; Huber TS; Berceli SA
J Vasc Surg; 2014 Dec; 60(6):1554-64. PubMed ID: 25043889
[TBL] [Abstract][Full Text] [Related]
15. A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study.
Schiavetta A; Maione C; Botti C; Marino G; Lillo S; Garrone A; Lanza L; Pagliari S; Silvestroni A; Signoriello G; Sica V; Cobellis G
Stem Cells Transl Med; 2012 Jul; 1(7):572-8. PubMed ID: 23197862
[TBL] [Abstract][Full Text] [Related]
16. Limb salvage using intramuscular injection of unfractionated autologous bone marrow mononuclear cells in critical limb ischemia: a prospective pilot clinical trial.
Gabr H; Hedayet A; Imam U; Nasser M
Exp Clin Transplant; 2011 Jun; 9(3):197-202. PubMed ID: 21649569
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative adjunctive stem cell treatment in patients with critical limb ischemia using a novel point-of-care device.
Kolvenbach R; Kreissig C; Cagiannos C; Afifi R; Schmaltz E
Ann Vasc Surg; 2010 Apr; 24(3):367-72. PubMed ID: 19896796
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.
Peeters Weem SM; Teraa M; de Borst GJ; Verhaar MC; Moll FL
Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):775-83. PubMed ID: 26460286
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life After Treatment with Autologous Bone Marrow Derived Cells in No Option Severe Limb Ischemia.
Peeters Weem SM; Teraa M; den Ruijter HM; de Borst GJ; Verhaar MC; Moll FL
Eur J Vasc Endovasc Surg; 2016 Jan; 51(1):83-9. PubMed ID: 26511056
[TBL] [Abstract][Full Text] [Related]
20. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
